# X-trodes

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/x-trodes

- Industry: Medical Devices & Equipment
- Headquarters: Herzliya, Israel
- Website: www.xtrodes.com
- Total disclosed funding: $4.5M
- Latest round: Seed (Oct 18, 2021)
- Investors on record: 2

## About

X-trodes Ltd., based in Israel, specializes in innovative medical technology, focusing on advanced electrophysiology data collection through its proprietary product, Smart Skin, enhancing patient monitoring and data accuracy in healthcare.Founded in 2019 in Herzliya, Israel, X-trodes Ltd. is dedicated to developing advanced electrophysiological monitoring solutions. The company was founded by Lilah Yifa, and has successfully raised EUR 2.7 million in funding from the European Innovation Council as part of their recent investment activities.X-trodes specializes in advanced electrophysiology data collection through its flagship product, Smart Skin, a medical-grade skin patch designed for real-time monitoring of electrophysiological signals. This innovative patch is uniquely flexible, soft, and ultra-thin, allowing it to adhere comfortably to various skin locations while collecting multi-modal data, including EEG, EMG, and ECG. By capturing data in patients' natural environments, Smart Skin addresses critical challenges in traditional healthcare settings, enhancing the understanding of various physiological conditions without the constraints of laboratory settings. The technology has been developed over a decade in Prof. Yael Hanein’s Neuro Engineering laboratory and is designed for healthcare providers, researchers, and clinical environments across multiple geographical markets, including North America and Europe. The company aims to support a wide array of end users, from individual patients to research institutions, medical professionals, and healthcare facilities seeking to enhance the quality and accessibility of care through real-time data monitoring.X-trodes generates revenue primarily through the sale of its Smart Skin patches, alongside potential subscription services for ongoing data analysis and reporting. The transaction structure is built on direct-to-consumer and B2B models, allowing healthcare providers and researchers to acquire products and services tailored to their operational needs. Partnerships with medical institutions and research organizations may also play a role in broadening the company's client base. While specific pricing details for Smart Skin and associated services are not disclosed, the company provides tailored solutions to meet the varying demands of its diverse clientele in the healthcare sector.In June 2023, X-trodes Ltd. raised EUR 2.7 million in venture funding from the European Innovation Council, part of a larger EUR 5.2 million grant and equity funding. This funding will facilitate the development and commercialization of their novel home sleep monitoring device. X-trodes plans to expand its market reach, targeting additional regions in Europe and North America by 2024.

## Funding rounds

- Seed, Oct 18, 2021, $4.5M — Japan-Israel Hi-Tech Ventures, Welltech Ventures

## Investors

- Japan-Israel Hi-Tech Ventures — Seed
- Welltech Ventures (https://capitalatlas.ai/funds/welltech-ventures) — Seed